To the Editor: Brain tumors (BTs) are defined as anomalous proliferations of brain tissue, whose severity extends on a spectrum from benign to malignant. Within the affected individual, they can manifest through a multitude of symptoms, from systemic fatigue and headaches to focal neurological deficits, seizures, and a plethora of others. Their etiology can be varied; they can originate from genetic mutations as a consequence of exposure to radiation or from weakened immune systems secondary to disease. From an epi-demiological perspective, the prevalence of BTs in Sub-Saharan Africa (SSA) has been low compared with high-income countries (HICs); it is stipulated that this is because of underreporting and inconsistencies with record keeping. Within the SSA context, underreporting could essentially be attributed to biopsychosocial factors such as lack of diagnostic resources, poor hospital attendance, and the influence of religious and societal norms preventing the uptake of treatment. Histologically, the most common types of BTs in the SSA are gliomas, meningiomas, pituitary adenomas, schwannomas, and medulloblastomas.
展开▼
